Published in Pigment Cell Melanoma Res on September 09, 2013
XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell (2001) 18.68
IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature (2002) 16.52
CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev (2004) 9.24
IRE1 signaling affects cell fate during the unfolded protein response. Science (2007) 9.01
Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol Cell Biol (2001) 8.03
Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells. Proc Natl Acad Sci U S A (2004) 7.03
ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response. Mol Cell Biol (2000) 5.73
Protein phosphatase 1--targeted in many directions. J Cell Sci (2002) 5.59
A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth. Int J Cancer (1987) 3.80
Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell (2002) 3.72
Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis. Science (2011) 3.29
PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress. J Biol Chem (2004) 2.74
Growth arrest and DNA damage-inducible protein GADD34 targets protein phosphatase 1 alpha to the endoplasmic reticulum and promotes dephosphorylation of the alpha subunit of eukaryotic translation initiation factor 2. Mol Cell Biol (2003) 2.70
Growth arrest and DNA damage-inducible protein GADD34 assembles a novel signaling complex containing protein phosphatase 1 and inhibitor 1. Mol Cell Biol (2001) 2.39
Divergent effects of PERK and IRE1 signaling on cell viability. PLoS One (2009) 2.30
ER stress signaling by regulated splicing: IRE1/HAC1/XBP1. Methods (2005) 2.25
Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8. J Invest Dermatol (2012) 2.02
Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism. N Engl J Med (1994) 1.98
GADD34-PP1c recruited by Smad7 dephosphorylates TGFbeta type I receptor. J Cell Biol (2004) 1.98
Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet (2012) 1.81
Deactivation of the kinase IKK by CUEDC2 through recruitment of the phosphatase PP1. Nat Immunol (2008) 1.54
Expression of glucose-regulated stress protein GRP78 is related to progression of melanoma. Histopathology (2009) 1.42
Adaptation to ER stress as a driver of malignancy and resistance to therapy in human melanoma. Pigment Cell Melanoma Res (2008) 1.33
Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins. FASEB J (2001) 1.33
Complementation of hypopigmentation in p-mutant (pink-eyed dilution) mouse melanocytes by normal human P cDNA, and defective complementation by OCA2 mutant sequences. J Invest Dermatol (1997) 1.29
Pink-eyed dilution protein controls the processing of tyrosinase. Mol Biol Cell (2002) 1.29
The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase. Pigment Cell Res (2002) 1.23
Pink-eyed dilution protein modulates arsenic sensitivity and intracellular glutathione metabolism. Mol Biol Cell (2002) 1.14
Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prions. PLoS One (2008) 1.13
Guanabenz. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension. Drugs (1983) 1.11
CHOP and the endoplasmic reticulum stress response in myelinating glia. Curr Opin Neurobiol (2009) 1.07
Thapsigargin sensitizes human melanoma cells to TRAIL-induced apoptosis by up-regulation of TRAIL-R2 through the unfolded protein response. Carcinogenesis (2007) 1.02
Endoplasmic reticulum stress inhibits cell cycle progression via induction of p27 in melanoma cells. Cell Signal (2012) 0.99
Protein synthesis in plasma cells is regulated by crosstalk between endoplasmic reticulum stress and mTOR signaling. Eur J Immunol (2010) 0.98
The unfolded protein response in melanocytes: activation in response to chemical stressors of the endoplasmic reticulum and tyrosinase misfolding. Pigment Cell Melanoma Res (2010) 0.84
p16(Ink4a) in melanocyte senescence and differentiation. J Natl Cancer Inst (2002) 2.09
Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8. J Invest Dermatol (2012) 2.02
IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: potential relevance to psoriasis. J Invest Dermatol (2013) 1.65
Patient perspectives on the management of atopic dermatitis. J Allergy Clin Immunol (2006) 1.55
On the etiology of contact/occupational vitiligo. Pigment Cell Res (2004) 1.55
Symmetric truncal aplasia cutis congenita following multifetal reduction of a sextuplet pregnancy. J Pediatr (2008) 1.48
Dissection of melanogenesis with small molecules identifies prohibitin as a regulator. Chem Biol (2005) 1.48
Spitz nevi: beliefs, behaviors, and experiences of pediatric dermatologists. JAMA Dermatol (2013) 1.46
Triazine-based tyrosinase inhibitors identified by chemical genetic screening. Pigment Cell Res (2005) 1.40
Pink-eyed dilution protein controls the processing of tyrosinase. Mol Biol Cell (2002) 1.29
Melanocortin 1 receptor genotype: an important determinant of the damage response of melanocytes to ultraviolet radiation. FASEB J (2010) 1.23
Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells. Mol Cancer Res (2008) 1.21
Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational research. Am J Transl Res (2009) 1.17
Pink-eyed dilution protein modulates arsenic sensitivity and intracellular glutathione metabolism. Mol Biol Cell (2002) 1.14
The misnomer "macrocephaly-cutis marmorata telangiectatica congenita syndrome": report of 12 new cases and support for revising the name to macrocephaly-capillary malformations. Arch Dermatol (2009) 1.10
Identification of novel pigmentation modulators by chemical genetic screening. J Invest Dermatol (2007) 1.06
Pityriasis rubra pilaris, type IV. Dermatol Online J (2005) 1.03
Practical guidelines for evaluation of loose anagen hair syndrome. Arch Dermatol (2009) 1.02
Association of MDM2 SNP309, age of onset, and gender in cutaneous melanoma. Clin Cancer Res (2009) 1.01
Mutations in the desmoglein 4 gene underlie localized autosomal recessive hypotrichosis with monilethrix hairs and congenital scalp erosions. J Invest Dermatol (2006) 1.00
The Tyr (albino) locus of the laboratory mouse. Mamm Genome (2004) 1.00
Evidence-based recommendations for the diagnosis and treatment of pediatric acne. Pediatrics (2013) 1.00
Infantile systemic hyalinosis. J Am Acad Dermatol (2004) 0.99
Degradation of tyrosinase induced by phenylthiourea occurs following Golgi maturation. Pigment Cell Res (2005) 0.99
Porokeratotic eccrine ostial and dermal duct nevus: a report of 2 cases and review of the literature. Am J Dermatopathol (2009) 0.99
From the rarest to the most common: insights from progeroid syndromes into skin cancer and aging. J Invest Dermatol (2009) 0.99
"Pediatric blaschkitis": expanding the spectrum of childhood acquired Blaschko-linear dermatoses. Pediatr Dermatol (2007) 0.96
Ocular albinism 1 protein: trafficking and function when expressed in Saccharomyces cerevisiae. Exp Eye Res (2005) 0.96
Ehlers-Danlos syndrome type VIII: periodontitis, easy bruising, marfanoid habitus, and distinctive facies. J Am Acad Dermatol (2006) 0.95
Planning for a brighter future: a review of sun protection and barriers to behavioral change in children and adolescents. Dermatol Online J (2008) 0.94
Celastrol synergistically enhances temozolomide cytotoxicity in melanoma cells. Mol Cancer Res (2009) 0.94
Disulfiram induces copper-dependent stimulation of reactive oxygen species and activation of the extrinsic apoptotic pathway in melanoma. Melanoma Res (2010) 0.94
Identification of quinolines that inhibit melanogenesis by altering tyrosinase family trafficking. Mol Pharmacol (2008) 0.93
The Dermatology Foundation: partnerships and programs focused on the future. J Invest Dermatol (2013) 0.92
Oxidative stress activates FUS1 and RLM1 transcription in the yeast Saccharomyces cerevisiae in an oxidant-dependent Manner. Mol Biol Cell (2004) 0.92
Extensive Riga-Fede disease of the lip and tongue. J Am Acad Dermatol (2002) 0.91
Inhibition of mitochondrial protein translation sensitizes melanoma cells to arsenic trioxide cytotoxicity via a reactive oxygen species dependent mechanism. Cancer Chemother Pharmacol (2008) 0.91
Mucosal dominant pemphigus vulgaris with anti-desmoplakin autoantibodies. J Am Acad Dermatol (2004) 0.90
Experience with molluscum contagiosum and associated inflammatory reactions in a pediatric dermatology practice: the bump that rashes. Arch Dermatol (2012) 0.90
The ocular albinism type 1 gene product, OA1, spans intracellular membranes 7 times. Exp Eye Res (2007) 0.89
Rab27b association with melanosomes: dominant negative mutants disrupt melanosomal movement. J Invest Dermatol (2002) 0.88
Antifolate activity of pyrimethamine enhances temozolomide-induced cytotoxicity in melanoma cells. Mol Cancer Res (2009) 0.88
Fluvastatin enhances sorafenib cytotoxicity in melanoma cells via modulation of AKT and JNK signaling pathways. Anticancer Res (2011) 0.88
Mucocutaneous neuromas: an underrecognized manifestation of PTEN hamartoma-tumor syndrome. Arch Dermatol (2006) 0.87
XIAP downregulation accompanies mebendazole growth inhibition in melanoma xenografts. Anticancer Drugs (2013) 0.86
Oral retinoid therapy for dermatologic conditions in children and adolescents. J Am Acad Dermatol (2003) 0.86
Heterologous expression of tyrosinase recapitulates the misprocessing and mistrafficking in oculocutaneous albinism type 2: effects of altering intracellular pH and pink-eyed dilution gene expression. Exp Eye Res (2005) 0.85
Accumulation of tyrosinase in the endolysosomal compartment is induced by U18666A. Pigment Cell Res (2003) 0.85
Pigmented plexiform neurofibroma: Distinction from a large congenital melanocytic nevus. J Am Acad Dermatol (2007) 0.84
The unfolded protein response in melanocytes: activation in response to chemical stressors of the endoplasmic reticulum and tyrosinase misfolding. Pigment Cell Melanoma Res (2010) 0.84
Abortive segmental perineal hemangioma. Dermatol Online J (2011) 0.84
Identification of the F1F0 mitochondrial ATPase as a target for modulating skin pigmentation by screening a tagged triazine library in zebrafish. Mol Biosyst (2005) 0.84
Sulforaphane synergistically enhances the cytotoxicity of arsenic trioxide in multiple myeloma cells via stress-mediated pathways. Oncol Rep (2012) 0.83
Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature. J Am Acad Dermatol (2005) 0.82
Radiation therapy for high-risk squamous cell carcinomas in patients with xeroderma pigmentosum: report of two cases and review of the literature. Dermatology (2011) 0.82
Correction of defective early tyrosinase processing by bafilomycin A1 and monensin in pink-eyed dilution melanocytes. Pigment Cell Res (2004) 0.81
Enhancement of arsenic trioxide cytotoxicity by dietary isothiocyanates in human leukemic cells via a reactive oxygen species-dependent mechanism. Leuk Res (2009) 0.81
Cole Disease Results from Mutations in ENPP1. Am J Hum Genet (2013) 0.80
25-hydroxycholesterol acts in the Golgi compartment to induce degradation of tyrosinase. Pigment Cell Res (2004) 0.80
Albendazole sensitizes cancer cells to ionizing radiation. Radiat Oncol (2011) 0.79
Report of a novel OCA2 gene mutation and an investigation of OCA2 variants on melanoma risk in a familial melanoma pedigree. J Dermatol Sci (2012) 0.79
Identification of compounds that bind mitochondrial F1F0 ATPase by screening a triazine library for correction of albinism. Chem Biol (2004) 0.78
Lichen planopilaris noted during etanercept therapy in a child with severe psoriasis. Pediatr Dermatol (2009) 0.77
DeoxyArbutin and its derivatives inhibit tyrosinase activity and melanin synthesis without inducing reactive oxygen species or apoptosis. J Drugs Dermatol (2012) 0.77
Cole disease: guttate hypopigmentation and punctate palmoplantar keratoderma. Arch Dermatol (2009) 0.77
Chemical genetic screening identifies tricyclic compounds that decrease cellular melanin content. J Invest Dermatol (2007) 0.77
Efficacy and safety of oral retinoids in psoriasis. Expert Opin Drug Saf (2005) 0.77
Juvenile myelomonocytic leukemia presenting with features of hemophagocytic lymphohistiocytosis in association with neurofibromatosis and juvenile xanthogranulomas. J Pediatr Hematol Oncol (2004) 0.76
X-linked recessive ichthyosis. Dermatol Online J (2005) 0.76
Patient-reported outcomes in pediatric patients with psoriasis undergoing etanercept treatment: 12-week results from a phase III randomized controlled trial. J Am Acad Dermatol (2010) 0.76
Congenital Spitz nevus clinically mimicking melanoma. J Am Acad Dermatol (2002) 0.76
The physician-scientist. J Invest Dermatol (2006) 0.76
Identification of agents that promote endoplasmic reticulum stress using an assay that monitors luciferase secretion. J Biomol Screen (2013) 0.75
Informed reasoning: repositioning of nitisinone to treat oculocutaneous albinism. J Clin Invest (2011) 0.75
Melanocytic proliferations in the setting of vulvar lichen sclerosus: diagnostic considerations. Pediatr Dermatol (2005) 0.75
Engineering a new mouse model for vitiligo. J Invest Dermatol (2012) 0.75
Morphea, diabetes mellitus type I, and celiac disease: case report and review of the literature. Pediatr Dermatol (2010) 0.75
Infantile granular parakeratosis: recognition of two clinical patterns. J Am Acad Dermatol (2004) 0.75
Cutaneous features of Crouzon syndrome with acanthosis nigricans. JAMA Dermatol (2013) 0.75
Eccrine angiomatous hamartoma. Dermatol Online J (2006) 0.75
Phacomatosis pigmentokeratotica associated with hemihypertrophy and a rhabdomyosarcoma of the abdominal wall. J Am Acad Dermatol (2006) 0.75
Dermatologists' attitudes, prescription, and counseling patterns for isotretinoin: a questionnaire-based study. J Drugs Dermatol (2015) 0.75
Juvenile amyopathic dermatomyositis. Dermatol Online J (2005) 0.75